| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999292 | Urologic Oncology: Seminars and Original Investigations | 2016 | 5 Pages |
Abstract
This data suggest that GATA3 is a sensitive marker in confirming invasive UC, and may be helpful in differentiating it from metastatic tumors of renal and prostatic origin. Furthermore, strong GATA3 expression was noted to have an effect on tumor size in patients with UC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kareem Hosny M.D., Momin T. M.D., Cynthia M.D.,